Nausea and vomiting. Nausea and vomiting
Conditions
Interventions
Intervention 1: In group one, patients recived 8 mg(two tablet) ondansetron orallry 30 minutes before surgery and recived 2 ml Distilled water intravenously after spinal anaesthesia. Intervention 2
Prevention
Placebo
In group one, patients recived 8 mg(two tablet) ondansetron orallry 30 minutes before surgery and recived 2 ml Distilled water intravenously after spinal anaesthesia
In group two, patients recived two tablets as same as ondansetron 30 minutes before surgery and recived intravenous 4 mg (2 cc) ondansetron after spinal anaesthesia
In group three, patients recived two tablets as same as ondansetron 30 minutes before surgery and recived 2 ml Distilled water intravenously after spinal anaesthesia
Sponsors
Arak University of Medical Sciences,Vice chancellor for research
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age between 18-45 and ASA Class I and II Exclusion criteria: history of postoperative nausea and vomiting; history of motion sickness; history of allergy to ondansetron; more than two failure in spinal anaesthesia; history of hyperemesis gravidarum.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: At 0, 1, 2, 4 and 6 hours after arrive to recovery. Method of measurement: Clinical assesment.;Consciousness. Timepoint: At 0, 1, 2, 4 and 6 hours after arrive to recovery. Method of measurement: Using Ramsay score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Afsaneh Norouzi
Arak University of Medical Sciences
Outcome results
None listed